Skip to main content

MediaCenter Panda Security

MediaCenter Panda Security

Virus in the name of WhatsApp! Now via email!

Posted: 21 Aug 2015 02:18 AM PDT

WhatsApp – Você recebeu uma menssagem de voz… Have you also received this notification and understood it to mean that you have a voice message in WhatsApp? Yea, well, it's nothing of the sort!

As we already warned you in May, cybercriminals are continuing to try and attack us via emails in which they urge us to download a supposed voice mail that is waiting for is in WhatsApp.

whatsapp fake

When you click on ‘Visualizar’, the only thing you'll end up downloading is a malware on your computer which could kidnap your files, paralyze your computer or any other type of unwanted action.

So, now you know… don't open any email like this. If you get one, send it straight to the trash!

whatsapp for pc

*** Published 07/05/2015

Profits are not the only thing brought by the voice calls in WhatsApp. We are sure that some of you are also worried about this.

According to RedesZone, this new service has reactivated, and made more believable, an old scam. Do you want to know how does it work? We will tell you! If you wonder how it works, keep reading…

  • You receive an email which informs you that you have a pending voice message, supposedly/technically from a friend/ one of your contacts.
  • If we want to listen to it, we just have to click on the "autoplay" button in the email.

whatsapp voice message

 

If there was any doubt, you are not downloading a voice message, instead you are downloading malware.

That's why, so you don't fall for this kind of scams, you should take this into account:

  • WhatsApp doesn't send notifications for pending messages.
  • If we look closely to the sender's address: darcy.bambrick@rogers.com, we will see it doesn't have to do anything with WhatsApp.
  • The application won't never refer to itself as Whats App.

The best thing you can do is just ignore these emails and install in your computer the best antivirus, which will block the malware in your computer.

The post Virus in the name of WhatsApp! Now via email! appeared first on MediaCenter Panda Security.

Comments

Post a Comment

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh
Post a Comment
Read More

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr
Post a Comment
Read More

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon!  Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly?  The answer isn't clear yet.  We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct.  But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – caused a higher rate of side
Post a Comment
Read More